Takada, Daisuke
Kunisawa, Susumu
Matsubara, Takeshi
Fushimi, Kiyohide
Yanagita, Motoko
Imanaka, Yuichi
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (H27-iryo-ippan-001,H30-seisaku-shitei-004)
Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (16H02634, 19H01075)
Article History
Received: 29 January 2020
Accepted: 25 March 2020
First Online: 15 April 2020
Compliance with ethical standards
:
: Potential financial conflicts of interest, Honoraria: Motoko Yanagita (Chugai Pharmaceutical, Kyowa Kirin).
: The study protocol was approved by the ethics committee of Kyoto University Graduate School and the Faculty of Medicine (approval number: R0135). This study was conducted in accordance with the ethical guidelines for medical and health research involving human participants issued by the Japanese National Government. These guidelines include a stipulation for the protection of patient anonymity.
: The data were anonymized, and the requirement for informed consent was waived.